Improving the core resilience of real-world hypergraphs

被引:0
作者
Do, Manh Tuan [1 ]
Shin, Kijung [1 ,2 ]
机构
[1] Korea Adv Inst Sci & Technol, Kim Jaechul Grad Sch AI, Seoul, South Korea
[2] Korea Adv Inst Sci & Technol, Sch Elect Engn, Seoul, South Korea
基金
新加坡国家研究基金会;
关键词
k-Core; Hypergraph; Deletion attack; Core resilience; MAINTENANCE;
D O I
10.1007/s10618-023-00958-0
中图分类号
TP18 [人工智能理论];
学科分类号
081104 ; 0812 ; 0835 ; 1405 ;
摘要
Interactions that involve a group of people or objects are omnipresent in practice. Some examples include the list of recipients of an email, the group of co-authors of a publication, and the users participating in online discussion threads. These interactions are modeled as hypergraphs in which each hyperedge is a set of nodes constituting an interaction. In a hypergraph, the k-core is the sub-hypergraph within which the degree of each node is at least k. Investigating the k-core structures is valuable in revealing some properties of the hypergraph, one of which is the network behavior when facing attacks. Networks in practice are often prone to attacks by which the attacker removes a portion of the nodes or hyperedges to weaken some properties of the networks. The resilience of the k-cores is an indicator of the robustness of the network against such attacks. In this work, we investigate the core resilience of real-world hypergraphs against deletion attacks. How robust are the core structures of real-world hypergraphs in these attack scenarios? Given the complexity of a real-world hypergraph, how should we supplement the hypergraph with augmented hyperedges to enhance its core resilience? In light of several empirical observations regarding core resilience, we present a two-step method that preserves and strengthens the core structures of the hypergraphs.
引用
收藏
页码:2438 / 2493
页数:56
相关论文
共 50 条
  • [31] Adherence to and Dropout from Liraglutide 3.0 mg Obesity Treatment in a Real-World Setting
    Ko, Hae-Jin
    Kim, Jin-Wook
    Lim, Soo
    JOURNAL OF OBESITY & METABOLIC SYNDROME, 2022, 31 (03) : 254 - 262
  • [32] Comparison of real-world outcomes of adalimumab and infliximab for patients with ulcerative colitis in the United States
    Sandborn, William J.
    Sakuraba, Atsushi
    Wang, Anthony
    Macaulay, Dendy
    Reichmann, William
    Wang, Song
    Chao, Jingdong
    Skup, Martha
    CURRENT MEDICAL RESEARCH AND OPINION, 2016, 32 (07) : 1233 - 1241
  • [33] Demand forecasting methods for spare parts logistics for aviation: a real-world implementation of the Bootstrap method
    Baisariyev, M.
    Bakytzhanuly, A.
    Serik, Y.
    Mukhanova, B.
    Babai, M. Z.
    Tsakalerou, M.
    Papadopoulos, C. T.
    FAIM 2021, 2021, 55 : 500 - 506
  • [34] Subcutaneous versus intravenous infliximab therapy - a real-world study: toward higher drug concentrations
    Ferreira, Ana Isabel
    Capela, Tiago Lima
    Arieira, Catia
    Xavier, Sofia
    Cotter, Jose
    EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY, 2024, 36 (11) : 1314 - 1318
  • [35] Efficacy and safety of dolutegravir/rilpivirine in real-world clinical practice. GeSIDA study 1119
    Palacios, R.
    Gomez-Ayerbe, C.
    Casado, J. L.
    Tejerina, F.
    Montes, M. L.
    Castano, M.
    Ocampo, A.
    Rial, D.
    Ribera, E.
    Galindo, M. J.
    Hidalgo, C.
    Farinas, C.
    Montero, M.
    Payeras, T.
    Fanjul, F.
    de la Torre, J.
    Santos, J.
    HIV MEDICINE, 2023, 24 (08) : 933 - 937
  • [36] Personalized group cognitive behavioural therapy for obesity: a longitudinal study in a real-world clinical setting
    Dalle Grave, Riccardo
    Calugi, Simona
    Bosco, Giovanna
    Valerio, Luigi
    Valenti, Chiara
    El Ghoch, Marwan
    Zini, Dante
    EATING AND WEIGHT DISORDERS-STUDIES ON ANOREXIA BULIMIA AND OBESITY, 2020, 25 (02) : 337 - 346
  • [37] Five years of safety profile of bevacizumab: an analysis of real-world pharmacovigilance and randomized clinical trials
    Wang, Li
    Fei, Yibo
    Qu, Han
    Zhang, Haiyang
    Wang, Yuanyuan
    Wu, Zhenghua
    Fan, Guorong
    JOURNAL OF PHARMACEUTICAL HEALTH CARE AND SCIENCES, 2024, 10 (01)
  • [38] Real-world bevacizumab utilization and outcomes among women with ovarian cancer in Europe and the United States
    Monberg, Matthew J.
    Hall, Jennifer P.
    Moon, Rebecca
    Khela, Keerun
    EUROPEAN JOURNAL OF GYNAECOLOGICAL ONCOLOGY, 2021, 42 (06) : 1252 - 1261
  • [39] A real-world study on characteristics, treatments and outcomes in US patients with advanced stage ovarian cancer
    Beachler, Daniel C.
    Lamy, Francois-Xavier
    Russo, Leo
    Taylor, Devon H.
    Dinh, Jade
    Yin, Ruihua
    Jamal-Allial, Aziza
    Dychter, Samuel
    Lanes, Stephan
    Verpillat, Patrice
    JOURNAL OF OVARIAN RESEARCH, 2020, 13 (01)
  • [40] Improving the robustness and resilience properties of maintenance
    Okoh, Peter
    Haugen, Stein
    PROCESS SAFETY AND ENVIRONMENTAL PROTECTION, 2015, 94 : 212 - 226